SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis

NCT03626948 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism

Interventions

DRUG: SK-1403

Sponsor

Sanwa Kagaku Kenkyusho Co., Ltd.